Global Ventricular Assist Devices Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Type (Left Ventricular Assist Device, Right Ventricular Assist Device, Bi-Ventricular Assist Device), By Application (Bridge-To-Candidacy, Bridge-To-Transplant, Destination Therapy), And By Geography - Forecasts From 2021 To 2026
- Published : Jul 2021
- Report Code : KSI061611772
- Pages : 131
The global ventricular assist devices market is evaluated at US$1,444.505 million for the year 2019 and is projected to grow at a CAGR of 10.35% reaching the market size of US$2,877.968 million by the year 2026.
Market overview.
Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.
The rising prevalence of cardiovascular diseases and an enormous gap between the demand and supply of donor hearts are the prime factors for driving the growth of the market. According to a World Health Organization report, nearly 17.9 million people around the globe die because of cardiovascular disease every year, which accounts for 31% of all deaths. Moreover increasing number of regulatory approvals also acts as a driving factor for the growth of the market. However high cost of ventricular assist devices along with the high cost of implantation works as the restraining factor for the growth of the market.
Impact of COVID-19 on the market.
The advent of COVID-19 had a positive impact on the market of ventricular assist devices as it became an integral part of the treatment procedures that were followed during the period to cure the patients. Moreover, WHO declared COVID-19 a pandemic as the increase in the number of cases was exponential in the initial months. The medical authorities advised the hospitals and other such medical institutions to stock up the requirements to never run out of supplies during the treatments, which in turn, increased the demand for VADs in the year 2020.
North America is anticipated to hold a substantial share in the market.
Global Ventricular Assist Devices Market Scope:
Report Metric | Details |
Market size value in 2019 | US$1,444.505 million |
Market size value in 2026 | US$2,877.968 million |
Growth Rate | CAGR of 10.35% from 2019 to 2026 |
Base year | 2019 |
Forecast period | 2021–2026 |
Forecast Unit (Value) | USD Million |
Segments covered | Type, Application, And Geography |
Regions covered | North America, South America, Europe, Middle East and Africa, Asia Pacific |
Companies covered | Calon Cardio, Jarvik Heart Inc., MAQUET Holding BV & Co. KG, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, Abiomed Inc., BiVACOR Inc., Abbott Laboratories, Berlin Heart GmbH |
Customization scope | Free report customization with purchase |
Segmentation
- By Type
- Left ventricular assist device (LVAD)
- Right ventricular assist device (RVAD)
- Bi-Ventricular Assist Device (BVAD)
- By Application
- Bridge-To-Candidacy (BTC)
- Bridge-To-Transplant (BTT)
- Destination Therapy (DT)
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- UK
- Others
- Middle East & Africa
- Saudi Arabia
- Israel
- Others
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Thailand
- Indonesia
- Others
- North America
Frequently Asked Questions (FAQs)
Q1. What will be the ventricular assist devices market size by 2026?
A1. The global ventricular assist devices market is projected to reach a market size of US$2,877.968 million in 2026.
Q2. What is the size of global ventricular assist devices market?
A2. Ventricular Assist Devices Market was valued at US$1,444.505 million in 2019.
Q3. What are the growth prospects for the ventricular assist devices market?
A3. The ventricular assist devices market is projected to grow at a CAGR of 10.35% over the forecast period.
Q4. Which region holds the maximum market share of the ventricular assist devices market?
A4. North America is anticipated to hold a substantial share in the ventricular assist devices market.
Q5. What factors are anticipated to drive the ventricular assist devices market growth?
A5. The major factors that drive the global ventricular assist devices market growth include an increase in the incidence of patients with heart failure and a shortage of heart donors.
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Ventricular Assist Devices Market Analysis, by Type
5.1. Introduction
5.2. Left ventricular assist device (LVAD)
5.3. Right ventricular assist device (RVAD)
5.4. Bi-Ventricular Assist Device (BVAD)
6. Ventricular Assist Devices Market Analysis, by Application
6.1. Introduction
6.2. Bridge-To-Candidacy (BTC)
6.3. Bridge-To-Transplant (BTT)
6.4. Destination Therapy (DT)
7. Ventricular Assist Devices Market Analysis, by Geography
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. UK
7.4.4. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. Calon Cardio
9.2. Jarvik Heart Inc.
9.3. MAQUET Holding BV & Co. KG
9.4. Medtronic PLC
9.5. SynCardia Systems LLC
9.6. Terumo Corporation
9.7. Abiomed Inc.
9.8. BiVACOR Inc.
9.9. Abbott Laboratories
9.10. Berlin Heart GmbH
Calon Cardio
Jarvik Heart Inc.
MAQUET Holding BV & Co. KG
Medtronic PLC
SynCardia Systems LLC
Terumo Corporation
Abiomed Inc.
BiVACOR Inc.
Abbott Laboratories
Berlin Heart GmbH
Related Reports
Report Name | Published Month | Get Sample PDF |
---|---|---|
Connected Agriculture Market Size & Share: Report, 2021-2026 | Sep 2021 | |
Pyrometer Market Size, Share & Trends: Industry Report, 2021-2026 | Jun 2021 | |
Radiotherapy Market Size & Share: Industry Report, 2021-2026 | Jul 2021 | |
Data Center Colocation Market Size & Share: Report, 2023 - 2028 | Jun 2023 | |
Industrial Enzymes Market Share & Trends: Report, 2024-2029 | Mar 2024 |